Comparison of the biological and functional characteristics of mesenchymal stem cells from intrahepatic and identical bone marrow
Open accessAbstract
In our privious work, our reseach group characterized a population of hepatic-sourced mesenchymal stem cells (MSCs) called MLpvNG2+ cells. In the present study, we compared the biological and functional characteristics of naïve MLpvNG2 cells with identical bone marrow-derived MSCs (niBM-MSCs) using in vitro (conditioned media) and in vivo (a well-set diethylnitrosamine (DEN)-induced liver fibrotic/cirrhotic murine model) procedures. The intrahepatic-sourced mesodermal MLpvNG2+ cells exhibited some biological characteristics (e.g., a set of surface markers) similar to those of extrahepatic niBM-MSCs. In responsed to signals of pathological conditions, such as singals of fibrotic/cirrhotic liver, MLpvNG2+ cells showed higher survival and favored differentiation into ALB(+) and G6Pc(+) hepatocytes, whereas niBM-MSCs predominantly differentiated into CK/KRT19(+) cholangiocytes. We identified C/EBPα/β expression as a biological characteristic differentiating these two populations of MSCs, wherein MLpvNG2+ cells are likely regulated by C/EBPβ transcriptional signaling, whereas niBM-MSCs are likely controlled by C/EBPα transcriptional signaling. Notably, although C/EBPα and C/EBPβ transcriptional signaling regulate hepatocyte and cholangiocyte fate, respectively, the expression of these proteins in MLpvNG2+ cells is, to our knowledge, reported for the first time in the present study. We used anti-C/EBP neutralizing antibodies (Abs) both in vitro and in vivo to determine the functional characteristics of these proteins. We conclude that the biological characteristics of these two populations of MSCs depend on their differential C/EBPα/β expression patterns.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The authors previously described functional benefits of ex vivo-expanded NG2-expressing cell subsets in the liver.
“We have previously described the functional benefits of ex vivo-expanded NG2-expressing cell subsets in the liver”
From New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis (2024) · cites this paper as [8]
The authors previously documented that PPWP-isolated NG2+ cells promote diseased liver endogenous repair functional recovery through direct development of specific cells after transplantation into a DEN mouse model.
“documented their ability to promote diseased liver endogenous repair functional recovery through the direct development of specific cells from the PPWP-isolated NG2+ cells after transplantation into a mouse model of orally administered diethylnitrosamine (DEN)-induced liver fibrosis/cirrhosis injury [8, 9].”
From New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis (2024) · cites this paper as [8]
Cells were infused at 6-7 weeks post-DEN when endogenous hepatic stem/progenitor cell activity decreased dramatically.
“Cells were infused at 6–7 weeks post-DEN when endogenous hepatic stem/progenitor cell activity decreased dramatically [8]”
From New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis (2024) · cites this paper as [8]
FCM assay revealed similar surface expression patterns of m-NG2/BMMSCs to classic m-BMMSCs and the ability of these cells to differentiate into osteogenic and adipogenic cells.
“the FCM assay revealed similar surface expression patterns of m-NG2/BMMSCs (Suppl. Fig. S1C) to classic m-BMMSCs and the ability of these cells to differentiate into osteogenic and adipogenic cells (Suppl. Fig. S1D) [8]”
From New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis (2024) · cites this paper as [8]
Oral administration of DEN results in bile duct damage, and m-BMMSCs are able to repair this damage.
“Oral administration of DEN results in bile duct damage, and m-BMMSCs are able to repair this damage [8].”
From New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis (2024) · cites this paper as [8]
Cites
Suk, K. T., Yoon, J., Kim, M. Y., Kim, C. W., Kim, J. K., Park, H., Hwang, S. G., Kim, D. J., Lee, B. S., Lee, S. H., et al. (2016) · Hepatology · doi:10.1002/hep.28693 · Cited by 303 · see citing works
Zhang, H., Siegel, C. T., Shuai, L., Lai, J., Zeng, L., Zhang, Y., Lai, X., Bie, P., & Bai, L. (2016) · Scientific Reports · doi:10.1038/srep21783 · Cited by 30 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Hu, D., Lai, J., Chen, Q., & Bai, L. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03817-x · Cited by 6 · see citing works
Self-citation
- Authors
- Lai, J., Jiang, S., Shuai, L., Zhang, Y., Xia, R., Chen, Q., & Bai, L.
- Affiliations
- Army Medical University (CN)
- Southwest University (CN)
- Corresponding author
- Bai, Lianhua
- Venue
- Stem Cell Research
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 55
- Pages
- 102477
- ISSN
- 1873-5061 (ISSN-L)
- OpenAlex
- W3183420277
- Cited by
- 12
- References
- 2
- Citations by year
- 2025: 1 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 1
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Stem Cell Research (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81570573, 81873586)
- Topics
- Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- mesenchymal stem cells, hepatic stem cells, bone marrow-derived mesenchymal stem cells, liver fibrosis, liver cirrhosis, hepatocyte differentiation, cholangiocyte differentiation, C/EBPα, C/EBPβ, transcriptional regulation
- MeSH terms
- Animals, Bone Marrow, Bone Marrow Cells, Cell Differentiation, Cells, Cultured, Hepatocytes, Mesenchymal Stem Cell Transplantation, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review